diabetes management
Western Sydney Diabetes adopts the mobile solution to automate patient engagement.
Jake Leach, executive VP and chief operating officer at Dexcom, joined MobiHealthNews to discuss the company's evolution and offerings beyond diabetes.
The investment brings Oura's valuation to more than $5 billion. The partnership enables a two-way data flow between the Oura Ring and Dexcom's continuous glucose monitor.
The partnership aims to raise patient safety, boost cost-effectiveness and improve care by combining Glytec's software with Roche's system.
It also incorporates gamification to encourage self-health monitoring.
Novo Nordisk is bringing its expertise in chronic disease management to Kakao's mobile diabetes app.
The Omnipod maker purchased assets related to Bigfoot Biomedical's pump-based automated insulin delivery technology.
They will deliver connected caps for insulin and titration alerts to Japanese healthcare providers and patients.
Also, Terumo has partnered with Glooko to enable diabetes data transfer from insulin patch pump to a data platform.
The pump currently integrates with the Dexcom G6 CGM and can be worn for up to 72 hours.